NCT06777082View on ClinicalTrials.gov

Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 30, 2025

Conditions
High Grade Serous Ovarian Cancer
Trial Locations (1)

40138

RECRUITING

IRCCS Azianda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER